Literature DB >> 1003240

Dopamine correlates of neurological and psychological status in untreated Parkinsonism.

M M Hoehn, T J Crowley, C O Rutledge.   

Abstract

Thirty-seven untreated Parkinsonism patients showed significant positive correlations among decreased excretion of free dopamine, MMPI scores indicative of schizophrenic-like looseness of thinking, and the severity of all Parkinsonism signs except tremor. The data could indicate that abnormalities of dopamine metabolism may underlie both the motor and mental abnormalities of Parkinsonism.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1003240      PMCID: PMC492496          DOI: 10.1136/jnnp.39.10.941

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  37 in total

1.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

Authors:  A CARLSSON; M LINDQVIST
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

2.  The excretion of dihydroxyphenylalanine, dopamine, and dihydroxyphenylacetic acid in neuroblastoma.

Authors:  T L SOURKES; R L DENTON; G F MURPHY; B CHAVEZ; S SAINT CYR
Journal:  Pediatrics       Date:  1963-04       Impact factor: 7.124

3.  An index of psychopathology (Ip) derived from clinicians' judgments of MMPI profiles.

Authors:  L K SINES; R J SILVER
Journal:  J Clin Psychol       Date:  1963-07

4.  Determination of urine dopamine.

Authors:  F BISCHOFF; A TORRES
Journal:  Clin Chem       Date:  1962-08       Impact factor: 8.327

5.  The occurrence, distribution and physiological role of catecholamines in the nervous system.

Authors:  A CARLSSON
Journal:  Pharmacol Rev       Date:  1959-06       Impact factor: 25.468

6.  Treatment of parkinsonism with levodopa.

Authors:  M D Yahr; R C Duvoisin; M J Schear; R E Barrett; M M Hoehn
Journal:  Arch Neurol       Date:  1969-10

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

8.  Excretion of dopamine in diseases of basal ganglia.

Authors:  A BARBEAU; G F MURPHY; T L SOURKES
Journal:  Science       Date:  1961-05-26       Impact factor: 47.728

9.  The quantitative determination of 3-methoxy-4-hydroxyphenylacetic acid (homovanillic acid) in urine.

Authors:  T L Sato
Journal:  J Lab Clin Med       Date:  1965-09

10.  [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors:  H EHRINGER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1960-12-15
View more
  4 in total

1.  Reduced rapid eye movement sleep latency in patients with Parkinson's disease.

Authors:  V S Kostić; V Susić; N Covicković-Sternić; Z Marinković; S Janković
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

2.  Prognostic implications of the motor symptoms of Parkinson's disease with respect to clinical, computertomographic and psychometric parameters.

Authors:  G Ransmayr; W Poewe; S Plörer; F Gerstenbrand; K Leidlmair; U Mayr
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

3.  Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain. Support for an excess methylation hypothesis for parkinsonism.

Authors:  C G Charlton; J Mack
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

4.  Depression in Parkinson's disease: health risks, etiology, and treatment options.

Authors:  Pasquale G Frisina; Joan C Borod; Nancy S Foldi; Harriet R Tenenbaum
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.